| Price | 0.625p on 07-10-2025 at 18:50:08 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.65p |
| Sell | 0.60p |
| Last Trade: | Sell 160,785.00 at 0.603p |
| Day's Volume: | 884,496 |
| Last Close: | 0.625p |
| Open: | 0.625p |
| ISIN: | GB00BYW8QM32 |
| Day's Range | 0.60p - 0.60p |
| 52wk Range: | 0.35p - 0.80p |
| Market Capitalisation: | £4.99m |
| VWAP: | 0.613428p |
| Shares in Issue: | 832.28m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
N4 Pharma Plc (N4P) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 160,785 | 0.603p | Ordinary |
14:02:55 - 07-Oct-25 |
| Sell* | 100,000 | 0.6175p | Ordinary |
13:04:24 - 07-Oct-25 |
| Sell* | 300,000 | 0.619p | Ordinary |
12:48:44 - 07-Oct-25 |
| Sell* | 1,000 | 0.60p | Ordinary |
11:51:23 - 07-Oct-25 |
| Buy* | 7,078 | 0.65p | Ordinary |
11:36:16 - 07-Oct-25 |
| Buy* | 4,618 | 0.65p | Ordinary |
11:34:07 - 07-Oct-25 |
| Sell* | 150,000 | 0.6224p | Ordinary |
10:03:23 - 07-Oct-25 |
| Sell* | 230 | 0.60p | Ordinary |
08:31:16 - 07-Oct-25 |
| Buy* | 19,923 | 0.642p | Ordinary |
15:06:38 - 06-Oct-25 |
| Buy* | 461 | 0.65p | Ordinary |
10:45:36 - 06-Oct-25 |
N4 Pharma Plc (N4P) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 25th Sep 2025 7:00 am | RNS | Interim Results |
| 23rd Sep 2025 7:00 am | RNS | Partnership with University of Strathclyde’s CMAC |
| 22nd Sep 2025 7:00 am | RNS | N4 Pharma’s Nuvec® Targets Lung Cancer Cells |
| 19th Sep 2025 7:00 am | RNS | Notice of Results, Analyst & Investor Presentation |
| 11th Sep 2025 7:00 am | RNS-R | Investor Event and Presentation |
| 30th Jul 2025 1:55 pm | RNS-R | Article on Nuvec®’s Potential in RNA Therapeutics |
| 14th Jul 2025 7:00 am | RNS-R | Investor Webinar |
| 8th Jul 2025 7:00 am | RNS | Directorate Change |
| 30th Jun 2025 2:15 pm | RNS | Result of AGM |
| 30th Jun 2025 7:00 am | RNS | AGM Statement |
